NCT03624712 Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
| NCT ID | NCT03624712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Tuebingen |
| Condition | Uterine Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 580 participants |
| Start Date | 2012-01 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 580 participants in total. It began in 2012-01 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluation of clinical, therapeutic and prognostic relevance of new experimental results as well as optimization of therapeutic models and development of a new algorithm for therapeutic plan and therapy in patients with uterine neoplasm
Eligibility Criteria
Inclusion Criteria: * Confirmed uterine malignancy ( cervical cancer, endometrial cancer, sarcoma) * If operable: surgical primary therapy: laparoscopic/robot-assisted or open radical gyneco-oncological surgery * Written consent * Willingness and ability to participate in all study-specific procedures * Age ≥ 18 years Exclusion Criteria: * Severe and acute general disease in the last 4 weeks * Acute or chronic psychiatric disorders * Other factors questioning study participation (e.g. acute psychosocial stress, insufficient understanding of nature and consequences of the study, inadequate skills of the German language)
Frequently Asked Questions
Who can join the NCT03624712 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Uterine Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03624712 currently recruiting?
Yes, NCT03624712 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Hospital Tuebingen to inquire about joining.
Where is the NCT03624712 trial being conducted?
This trial is being conducted at Tübingen, Germany.
Who is sponsoring the NCT03624712 clinical trial?
NCT03624712 is sponsored by University Hospital Tuebingen. The trial plans to enroll 580 participants.